Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation. - Wikidata - wikimedia - TriplyDB

Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation.

Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation.

http://www.wikidata.org/entity/Q36938841

about

Predicting outcome after childhood brain injury Perinatal biomarkers in prematurity: early identification of neurologic injury The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling Cerebral microbleeds after use of extracorporeal membrane oxygenation in children.Prematurity: present and future.Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular Injury.Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival Rewarming Rate During Cardiopulmonary Bypass Is Associated With Release of Glial Fibrillary Acidic Protein.Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.Glial fibrillary acidic protein as a biomarker for periventricular white matter injury.Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas Glial fibrillary acidic protein as a biomarker for brain injury in neonatal CHD.The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model Plasma glial fibrillary acidic protein levels in children with sickle cell disease.Biomarkers of hypoxic-ischemic encephalopathy in newborns.Intensive care of the pediatric ventricular assist device patient.Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions.Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD.Noteworthy Literature in 2015: Anesthesia for Congenital Heart Disease.Osteopontin Is a Blood Biomarker for Microglial Activation and Brain Injury in Experimental Hypoxic-Ischemic Encephalopathy.Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation.Neuromonitoring of neonatal extracorporeal membrane oxygenation patients using serial cranial ultrasounds.Glial fibrillary acidic protein plasma levels are correlated with degree of hypothermia during cardiopulmonary bypass in congenital heart disease surgery.Tetramethylpyrazine Nitrone Improves Neurobehavioral Functions and Confers Neuroprotection on Rats with Traumatic Brain Injury.Association of nadir oxygen delivery on cardiopulmonary bypass with serum glial fibrillary acid protein levels in paediatric heart surgery patients.The effect of extracorporeal membrane oxygenation therapy on systemic oxidative stress injury in a porcine model.Effects of pumpless extracorporeal lung assist on hemodynamics, gas exchange and inflammatory cascade response during experimental lung injury.Transcriptional Alterations in the Trigeminal Ganglia, Nucleus and Peripheral Blood Mononuclear Cells in a Rat Orofacial Pain Model.Neurologic Outcomes After Extracorporeal Membrane Oxygenation: A Systematic Review Incidence, Outcome, and Predictors of Intracranial Hemorrhage in Adult Patients on Extracorporeal Membrane Oxygenation: A Systematic and Narrative Review

P2860

Q26825547-50602173-7559-4D73-A6DF-BA850CDF8280 Q26853539-173A53F0-E43C-4F58-A4D5-82EDB8DDB2F4 Q28397332-37AE6FEB-BEBD-47A6-A97D-C9B4132A7C35 Q33570294-C313A137-6C03-45A1-A170-1C1A38817F8B Q34143561-64AB4855-94ED-4FBB-9BBF-873605695759 Q35071019-5C0EA776-D9B5-40EB-A93E-6CA60C723BB4 Q35570888-696C6D54-CAFF-4BC9-A938-D915F9035A61 Q35684987-1C548099-6C61-445B-876D-90B6BF1F1E40 Q35912141-D327D28F-87F1-41B3-909F-29FBCAE6F970 Q36019111-1494E759-7F3C-4454-AB69-B0ECAC0581F6 Q36122355-6635D997-9C34-47CD-971F-C68C80BE3BC1 Q36689419-FCD08BF9-41E3-443D-A6DF-3B99C6AEAC95 Q37004470-C2D05FFD-C450-485E-A918-06BD1CF21A73 Q37023701-C042C755-ABEB-47D1-81D0-BD87D1121813 Q37116179-DABF6513-D93F-4B41-85F4-015F169C4920 Q37153832-0E77A849-1137-4550-9BF2-374265A4BB6C Q37407877-F87ECBEA-93CB-4CD2-8A7D-F8E10CD5066C Q38058092-10E2588B-119E-49DF-8544-34FFB17D265E Q38117319-2A162480-6E47-488C-94B5-5BB95B8BA635 Q38266067-A8B626E1-55F8-4B26-BE33-DFD0E3295DEE Q38611283-2664150F-03B0-4F0C-A098-EB415ED11CAC Q38702392-E55D43E2-F408-47E4-9D36-20672E503006 Q41087777-0C6D33E4-ADBE-45F8-9A16-E0B3218CAE38 Q41448024-47492D3C-C0C6-425B-A580-AA9ED6679D05 Q42397848-44F1E4D0-D2A7-4F26-ADD9-96E1CD2EEE52 Q47347263-7D8A6A6E-13CD-43FE-ACA9-19E83AA3F4A3 Q48252219-97BCA132-859E-4F64-9658-933505CEE25A Q48668868-42A18BC7-8757-4885-929A-8CE25772D52B Q48939981-2C65345A-C35D-43A4-BF23-8F5607BFA705 Q49754726-F1BEFDE8-5017-4B84-8D71-D77E7DD44438 Q55689248-AEDC0776-1438-419E-A2E2-47794B28F58B Q57173400-04EC56C2-30B5-48D9-8FCC-E2024C64990A Q57176928-964774E0-8439-46B9-99CF-BE273ADB9DFD

P2860

Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation.

http://www.wikidata.org/entity/Q36938841

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Glial fibrillary acidic protei ...... orporeal membrane oxygenation.

@en

type

label

Glial fibrillary acidic protei ...... orporeal membrane oxygenation.

@en

prefLabel

Glial fibrillary acidic protei ...... orporeal membrane oxygenation.

@en

P1433

Q36938841-8018B4BE-C742-43E4-B4D8-4DD220DFEE39

P1476

Q36938841-F5E8393C-E884-4911-A212-D65764D7A7FA

P2093

Q36938841-19EB5595-A2FC-42B8-8E78-8D52A0E13839

Q36938841-48F9E780-3678-441D-9153-93E96D1FCD10

Q36938841-5AF01497-FCFD-46E0-9306-1EF562324058

Q36938841-9F12F401-4836-4D7A-AF0E-DC0AB1AC6EA0

Q36938841-D7CA0C7A-9692-47DB-B7E1-F198719AC5E2

Q36938841-E56584EF-BDFC-482C-9B27-5C9F075D6A30

P2860

Q36938841-0E911A1B-36F8-4CFA-9C72-03412AC01790

Q36938841-28011688-DA30-4B02-96BE-11934F7441DA

Q36938841-2948564F-83C1-4D98-ADAC-E0DE76523088

Q36938841-341F14A7-EE24-48C2-B206-0E021E9CF9CC

Q36938841-34365596-4DDB-4C88-AE1B-67A0653A0B12

Q36938841-3B3962DA-F198-4276-A721-103BCBC0ACA7

Q36938841-3CC1301C-86D9-4C5C-9729-16DB5C409B1E

Q36938841-453946BE-C614-46F7-A927-6DA45898A6FF

Q36938841-4E58211B-2185-4ABD-8E76-1CE11BD042D7

Q36938841-5A849323-21A0-40B6-9186-736942AB47D1

P304

Q36938841-1CFC08DB-7749-49F9-8F15-5E4481E59B25

P31

Q36938841-DBE82D54-1426-41D8-9537-2625DE3DE1DC

P356

Q36938841-3E1D74F6-DDEA-4FE9-8B25-085F22A9EE76

P433

Q36938841-4F1FCEDA-376F-400F-9C81-A2A1AE8465A6

P478

Q36938841-82D71029-4E3E-475A-9F41-1B22EF4CBF66

P50

Q36938841-C3A1A7BE-BA66-4960-8295-E9EE36D09505

P577

Q36938841-D1DCA387-6481-4B90-820D-ACF38570534E

P698

Q36938841-DAA43AB6-9826-4DCA-9CC7-1C67C5C86BA4

P921

Q36938841-EE53650E-9180-4CDE-A663-788D37942426

Q36938841-F6D7B1D7-59BF-4851-B9A6-C6AF67896E2F

P932

Q36938841-533D3EBD-8D02-4140-B875-D13C23940A00

P356

PCC.0B013E3181FE3EC7

P1433

Pediatric Critical Care Medicine

P1476

Glial fibrillary acidic protei ...... corporeal membrane oxygenation

@en

P2093

Allen Everett

http://www.w3.org/2001/XMLSchema#string

Carol B Thompson

http://www.w3.org/2001/XMLSchema#string

Ernest Graham

http://www.w3.org/2001/XMLSchema#string

Jamie McElrath Schwartz

http://www.w3.org/2001/XMLSchema#string

John J Strouse

http://www.w3.org/2001/XMLSchema#string

William Savage

http://www.w3.org/2001/XMLSchema#string

P2860

Controversial significance of early S100B levels after cardiac surgery

Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracorporeal membrane oxygenation.

Cerebral blood flow and oxygenation during venoarterial and venovenous extracorporeal membrane oxygenation in the newborn lamb.

Outcomes after extracorporeal cardiopulmonary resuscitation (ECPR) following refractory pediatric cardiac arrest in the intensive care unit

Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.

Follow-up of newborns treated with extracorporeal membrane oxygenation: a nationwide evaluation at 5 years of age.

An ELISA for glial fibrillary acidic protein.

Survival outcomes after extracorporeal cardiopulmonary resuscitation instituted during active chest compressions following refractory in-hospital pediatric cardiac arrest.

Astrocytes in cerebral ischemic injury: morphological and general considerations.

Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke.

P304

572-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PCC.0B013E3181FE3EC7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21057367

http://www.w3.org/2001/XMLSchema#string

P921

extracorporeal membrane oxygenation

P932

3686089

http://www.w3.org/2001/XMLSchema#string